Algemeen Ziekenhuis Alma
- Address
- Ringlaan 15, 9900 Eeklo, Belgium
Algemeen Ziekenhuis Alma - Dermatology Research Center
Algemeen Ziekenhuis Alma is actively engaged in advancing dermatological care through clinical research focused on therapeutic drug monitoring and optimization of biologic treatments. The center specializes in investigating innovative approaches to managing chronic inflammatory skin conditions using cutting-edge therapeutic strategies.
- Proactive therapeutic drug monitoring (TDM) in dermatologic conditions
- Biologic therapies for moderate-to-severe psoriasis including secukinumab, ixekizumab, and guselkumab
- Sustained disease control optimization in chronic inflammatory skin diseases
The research center is particularly committed to evaluating personalized treatment approaches in moderate-to-severe psoriasis, examining how proactive monitoring strategies compare to standard care protocols in maintaining long-term disease control and improving patient outcomes with novel biologic agents.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
- 1Universitair Ziekenhuis Gent1active
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 307 other sites in Belgium
Therapeutic Area Benchmark — Belgium
Select a therapeutic area to compare against other sites in Belgium.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Belgium
Market Share
Country: Belgium
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Algemeen Ziekenhuis Alma
lock Showing 1 of 3 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Randomized Controlled Trial Comparing Proactive Therapeutic Drug Monitoring with Routine Care Using Secukinumab, Ixekizumab, or Guselkumab in Moderate-to-Severe Psoriasis | Universitair Ziekenhuis Gent | Phase III | Recruiting | Nov 2024 | — |
IMP list
lock Showing 1 of 6 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Acetylsalicylic Acid | 1 | Unknown | 2017-07-31 | 2017-07-31 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.